23andMe will get FDA approval, however solely to check uncommon Bloom syndrome
For over a yr now, 23andMe has been successfully banned from providing its US clients well being-associated genetic exams. The corporate continues to be promoting its private DNA kits, however the info it might present is restricted to ancestry-associated stories and uncooked genetic knowledge. The US Meals and Drug Administration (FDA) was behind the unique clampdown in 2013, however this week it is given the corporate its blessing for a brand new check. With the recent approval, 23andMe can now supply to search for indicators of Bloom syndrome, a uncommon dysfunction which is characterised by brief stature, solar-delicate pores and skin and elevated most cancers danger. Whereas this can be a particular check, somewhat than the broader well being stories it provided earlier than, 23andMe calls it an “necessary first step” to providing detailed genetic info within the US as soon as extra.